969 Shares in Lam Research Co. (NASDAQ:LRCX) Bought by Unique Wealth Strategies LLC

Unique Wealth Strategies LLC purchased a new stake in shares of Lam Research Co. (NASDAQ:LRCXFree Report) during the fourth quarter, HoldingsChannel reports. The fund purchased 969 shares of the semiconductor company’s stock, valued at approximately $759,000.

A number of other institutional investors and hedge funds have also bought and sold shares of LRCX. Orion Capital Management LLC purchased a new position in shares of Lam Research during the third quarter valued at about $25,000. BluePath Capital Management LLC purchased a new position in shares of Lam Research during the third quarter valued at about $28,000. OFI Invest Asset Management purchased a new position in shares of Lam Research during the third quarter valued at about $30,000. Asset Dedication LLC grew its position in shares of Lam Research by 56.7% during the third quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock valued at $30,000 after purchasing an additional 17 shares in the last quarter. Finally, Valued Wealth Advisors LLC purchased a new position in shares of Lam Research during the fourth quarter valued at about $30,000. 84.61% of the stock is owned by institutional investors.

Lam Research Stock Up 2.7 %

Shares of LRCX traded up $23.90 during midday trading on Friday, hitting $925.37. 1,397,129 shares of the company’s stock traded hands, compared to its average volume of 1,010,097. Lam Research Co. has a 1 year low of $493.42 and a 1 year high of $1,007.39. The firm’s fifty day moving average is $943.67 and its 200-day moving average is $809.10. The company has a current ratio of 2.82, a quick ratio of 2.02 and a debt-to-equity ratio of 0.56. The stock has a market capitalization of $121.32 billion, a price-to-earnings ratio of 34.03, a price-to-earnings-growth ratio of 3.20 and a beta of 1.51.

Lam Research (NASDAQ:LRCXGet Free Report) last released its earnings results on Wednesday, April 24th. The semiconductor company reported $7.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.26 by $0.53. Lam Research had a return on equity of 45.96% and a net margin of 25.35%. The firm had revenue of $3.79 billion for the quarter, compared to the consensus estimate of $3.72 billion. During the same period in the prior year, the firm earned $6.99 EPS. The firm’s revenue was down 2.0% on a year-over-year basis. As a group, sell-side analysts anticipate that Lam Research Co. will post 29.46 earnings per share for the current year.

Lam Research Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 3rd. Investors of record on Wednesday, March 13th were given a $2.00 dividend. This represents a $8.00 annualized dividend and a dividend yield of 0.86%. The ex-dividend date of this dividend was Tuesday, March 12th. Lam Research’s payout ratio is 29.42%.

Insider Activity at Lam Research

In other Lam Research news, Director Abhijit Y. Talwalkar sold 882 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $972.03, for a total transaction of $857,330.46. Following the sale, the director now directly owns 10,541 shares of the company’s stock, valued at approximately $10,246,168.23. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Lam Research news, Director Abhijit Y. Talwalkar sold 882 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $972.03, for a total transaction of $857,330.46. Following the sale, the director now directly owns 10,541 shares of the company’s stock, valued at approximately $10,246,168.23. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Christina Corrreia sold 647 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $972.03, for a total value of $628,903.41. Following the sale, the chief accounting officer now directly owns 5,541 shares in the company, valued at $5,386,018.23. The disclosure for this sale can be found here. Insiders have sold a total of 7,029 shares of company stock valued at $6,559,489 in the last ninety days. Company insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on LRCX shares. Needham & Company LLC restated a “buy” rating and set a $1,030.00 price objective on shares of Lam Research in a research report on Thursday. Mizuho raised their price objective on Lam Research from $935.00 to $960.00 and gave the company a “buy” rating in a research report on Thursday. Cantor Fitzgerald reiterated a “neutral” rating and issued a $1,100.00 price target on shares of Lam Research in a research report on Thursday. The Goldman Sachs Group boosted their price objective on Lam Research from $700.00 to $912.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th. Finally, Deutsche Bank Aktiengesellschaft began coverage on Lam Research in a research note on Thursday, April 11th. They set a “hold” rating and a $1,000.00 price objective on the stock. Six investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $950.85.

Read Our Latest Research Report on LRCX

Lam Research Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Read More

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.